These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 39630333)
1. Evaluating the diagnostic value of Tian X; Wang Y; Zhang Y; Teng Y; Cui Z; Liu J Jpn J Radiol; 2024 Dec; ():. PubMed ID: 39630333 [TBL] [Abstract][Full Text] [Related]
2. Evaluating the diagnostic performance of [ Lv J; Zheng K; Jiang C; Yang J; Peng X; Ye H; Zhang Y Eur Radiol; 2024 Nov; ():. PubMed ID: 39604653 [TBL] [Abstract][Full Text] [Related]
4. Comparative Study of [ Gao H; Chen J; Yang Z; Zhu Z; He L; Zhang W; Chen X; Zhang J ACS Appl Mater Interfaces; 2024 Dec; 16(49):67523-67531. PubMed ID: 39607746 [No Abstract] [Full Text] [Related]
5. [ Michalski K; Kosmala A; Hartrampf PE; Heinrich M; Serfling SE; Schlötelburg W; Buck AK; Meining A; Werner RA; Weich A J Nucl Med; 2024 Dec; 65(12):1899-1903. PubMed ID: 39477500 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic Potential of Supplemental Static and Dynamic Röhrich M; Daum J; Gutjahr E; Spektor AM; Glatting FM; Sahin YA; Buchholz HG; Hoppner J; Schroeter C; Mavriopoulou E; Schlamp K; Grott M; Eichhorn F; Heußel CP; Kauczor HU; Kreuter M; Giesel F; Schreckenberger M; Winter H; Haberkorn U J Nucl Med; 2024 Jun; 65(6):872-879. PubMed ID: 38604763 [TBL] [Abstract][Full Text] [Related]
7. Ruan D; Sun J; Han C; Cai J; Yu L; Zhao L; Pang Y; Zuo C; Sun L; Wang Z; Tan G; Qu X; Chen H Theranostics; 2024; 14(18):6935-6946. PubMed ID: 39629119 [No Abstract] [Full Text] [Related]
8. Chan SC; Chiu TL; Ng SH; Kao HW; Tsai ST; Liu SH Ann Nucl Med; 2024 Nov; ():. PubMed ID: 39589672 [TBL] [Abstract][Full Text] [Related]
9. Exploring the Potential Value of [ 68 Ga]Ga-FAPI-46 PET/CT for Molecular Assessment of Fibroblast Activation in Interstitial Lung Disease : A Single-Center Pilot Study. Bahtouee M; Jafari E; Khazaei M; Aram N; Amini A; Jokar N; Ahmadzadehfar H; Gholamrezanezhad A; Assadi M Clin Nucl Med; 2025 Jan; 50(1):e17-e25. PubMed ID: 39466620 [TBL] [Abstract][Full Text] [Related]
10. Assessing the Value of Sun Y; Xu J; Qiao Y; Zhang J; Pan H; Xu X; Song S Radiol Imaging Cancer; 2024 Nov; 6(6):e230195. PubMed ID: 39422573 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
12. Performance of fibroblast activating protein inhibitor PET imaging for pancreatic neoplasms assessment: a systematic review and meta-analysis. Tang R; Liu M; Shu Q; Chen X; Cai L Eur Radiol; 2024 Dec; 34(12):7804-7812. PubMed ID: 38907099 [TBL] [Abstract][Full Text] [Related]
13. Comparison of [ Zhong K; Chen H; Hou P; Cheng L; Guo W; Li Y; Lv J; Ke M; Wu X; Lei Y; Liu C; Hong C; Wang X Eur J Nucl Med Mol Imaging; 2024 Nov; ():. PubMed ID: 39601894 [TBL] [Abstract][Full Text] [Related]
14. [68Ga]Ga-FAPI-46 PET/CT for Staging Suspected/Confirmed Lung Cancer: Results on the Surgical Cohort Within a Monocentric Prospective Trial. Zanoni L; Fortunati E; Cuzzani G; Malizia C; Lodi F; Cabitza VS; Brusa I; Emiliani S; Assenza M; Antonacci F; Giunchi F; Degiovanni A; Ferrari M; Natali F; Galasso T; Bandelli GP; Civollani S; Candoli P; D'Errico A; Solli P; Fanti S; Nanni C Pharmaceuticals (Basel); 2024 Nov; 17(11):. PubMed ID: 39598380 [TBL] [Abstract][Full Text] [Related]
15. Serum and urine nucleic acid screening tests for BK polyomavirus-associated nephropathy in kidney and kidney-pancreas transplant recipients. Maung Myint T; Chong CH; von Huben A; Attia J; Webster AC; Blosser CD; Craig JC; Teixeira-Pinto A; Wong G Cochrane Database Syst Rev; 2024 Nov; 11(11):CD014839. PubMed ID: 39606952 [TBL] [Abstract][Full Text] [Related]
16. Detection of tumour heterogeneity in patients with advanced, metastatic castration-resistant prostate cancer on [ Pabst KM; Mei R; Lückerath K; Hadaschik BA; Kesch C; Rawitzer J; Kessler L; Bodensieck LS; Hamacher R; Pomykala KL; Fanti S; Herrmann K; Fendler WP Eur J Nucl Med Mol Imaging; 2024 Dec; 52(1):342-353. PubMed ID: 39207485 [TBL] [Abstract][Full Text] [Related]
17. Comparative Diagnostic Value of 18F-FDG-PET-CT and Intraoperative Examination in Cervical Cancer Staging. Malenković G; Malenković J; Tomić S; Šljivo A; Gavrankapetanović-Smailbegović F; Tomić S Medicina (Kaunas); 2024 Oct; 60(11):. PubMed ID: 39596943 [No Abstract] [Full Text] [Related]
18. Value of [ Lou K; Wang J; He H; Wang Y; Mi Y; Li W; Chen L; Zhang Y; Mao Y; Lin J; Fu H; Yu C J Nucl Med; 2024 Dec; 65(12):1884-1890. PubMed ID: 39542699 [TBL] [Abstract][Full Text] [Related]
19. The impact of qualitative [18F]FDG PET/CT in predicting clinical outcomes of post-surgical differentiated thyroid cancer patients with elevated thyroglobulin and negative radioiodine whole-body scan. Ha LN; Phuong NT; Son MH BMC Surg; 2024 Nov; 24(1):377. PubMed ID: 39593022 [TBL] [Abstract][Full Text] [Related]
20. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]